Concepedia

Sumie Koike

SK

16

Publications

1.6K

Citations

15

H-Index

2009

Active since

Affiliations

Japanese Foundation For Cancer Research(Current)

The University of Tokyo

Massachusetts General Hospital

The Cancer Institute Hospital

Harvard University

Sumie Koike is an author at Japanese Foundation For Cancer Research specializing in medicine, tumor biology, and cell biology.

Top concepts

Publications per year

2009–2022

16

Publications

16

Two Novel ALK Mutations Mediate Acquired Resistance to the Next-Generation ALK Inhibitor Alectinib

Ryohei Katayama, Luc Friboulet, Sumie Koike et al. · Clinical Cancer Research · 2014 · 285 citations · Full text

Platelets Promote Tumor Growth and Metastasis via Direct Interaction between Aggrus/Podoplanin and CLEC-2

Satoshi Takagi, Shigeo Sato, Tomoko Oh‐hara et al. · PLoS ONE · 2013 · 205 citations · Full text

Cabozantinib Overcomes Crizotinib Resistance in ROS1 Fusion–Positive Cancer

Ryohei Katayama, Yuka Kobayashi, Luc Friboulet et al. · Clinical Cancer Research · 2014 · 198 citations · Full text

P-glycoprotein Mediates Ceritinib Resistance in Anaplastic Lymphoma Kinase-rearranged Non-small Cell Lung Cancer

Ryohei Katayama, Takuya Sakashita, Noriko Yanagitani et al. · EBioMedicine · 2015 · 139 citations · Full text

The new-generation selective ROS1/NTRK inhibitor DS-6051b overcomes crizotinib resistant ROS1-G2032R mutation in preclinical models

Ryohei Katayama, Bo Gong, Noriko Togashi et al. · Nature Communications · 2019 · 135 citations · Full text

Rows per page

1–5 of 16